These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7555187)

  • 1. Antithrombotic therapy for venous thromboembolic disease.
    Hyers TM; Hull RD; Weg JG
    Chest; 1995 Oct; 108(4 Suppl):335S-351S. PubMed ID: 7555187
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombotic therapy for venous thromboembolic disease.
    Hyers TM; Hull RD; Weg JG
    Chest; 1986 Feb; 89(2 Suppl):26S-35S. PubMed ID: 3510827
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithrombotic therapy for venous thromboembolic disease.
    Hyers TM; Hull RD; Weg JG
    Chest; 1992 Oct; 102(4 Suppl):408S-425S. PubMed ID: 1395825
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antithrombotic therapy and its laboratory monitoring (lecture)].
    Vavilova TV
    Klin Lab Diagn; 2004 Dec; (12):21-32. PubMed ID: 15739768
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evidence-based guidelines for prevention and therapy of venous thromboembolism].
    Falciani M; Dilaghi B; Conti AA; Caciolli S; Gensini GF
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):27-35. PubMed ID: 11253337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of venous thromboembolic (VTE) disease--Part II: Treatment.
    Kayser SR
    Prog Cardiovasc Nurs; 1996; 11(1):36-40, 46. PubMed ID: 8657708
    [No Abstract]   [Full Text] [Related]  

  • 7. New anticoagulant drugs: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Weitz JI; Hirsh J; Samama MM
    Chest; 2004 Sep; 126(3 Suppl):265S-286S. PubMed ID: 15383475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unresolved issues in the prevention and treatment of venous thromboembolism.
    Agnelli G
    Semin Thromb Hemost; 2002 Jun; 28 Suppl 2():33-40. PubMed ID: 12073178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for the use of thrombolytic therapy. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology.
    Ludlam CA; Bennett B; Fox KA; Lowe GD; Reid AW
    Blood Coagul Fibrinolysis; 1995 May; 6(3):273-85. PubMed ID: 7654941
    [No Abstract]   [Full Text] [Related]  

  • 10. Antithrombotic therapy for venous thromboembolic disease.
    Hyers TM; Hull RD; Weg JG
    Chest; 1989 Feb; 95(2 Suppl):37S-51S. PubMed ID: 2644102
    [No Abstract]   [Full Text] [Related]  

  • 11. Future of anticoagulant therapy.
    Harenberg J; Wehling M
    Cardiovasc Ther; 2011 Oct; 29(5):291-300. PubMed ID: 20626401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for antithrombotic therapy in pediatric patients.
    Andrew M; Michelson AD; Bovill E; Leaker M; Massicotte MP
    J Pediatr; 1998 Apr; 132(4):575-88. PubMed ID: 9580753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment and prevention of venous thromboembolic events: present and future antithrombotic agents].
    Drouet L
    Bull Acad Natl Med; 2003; 187(1):85-96; discussion 96-7. PubMed ID: 14556456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Monagle P; Chan A; Massicotte P; Chalmers E; Michelson AD
    Chest; 2004 Sep; 126(3 Suppl):645S-687S. PubMed ID: 15383489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of intravenous thrombolytic drugs for acute myocardial infarction.
    Naylor CD; Bronskill S; Goel V
    Can J Cardiol; 1993; 9(6):553-8. PubMed ID: 8221354
    [No Abstract]   [Full Text] [Related]  

  • 16. Antithrombotic therapy: the expanding role of low molecular weight heparin.
    Turpie AG
    Indian Heart J; 1997; 49(5):489-92. PubMed ID: 9505014
    [No Abstract]   [Full Text] [Related]  

  • 17. Strategies for cost-effective prevention and treatment of venous thromboembolism. Introduction.
    Nutescu EA
    Am J Health Syst Pharm; 2004 Dec; 61(23 Suppl 7):S3-4. PubMed ID: 15597572
    [No Abstract]   [Full Text] [Related]  

  • 18. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
    Ruiz Manzano J; Monreal M
    Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
    [No Abstract]   [Full Text] [Related]  

  • 19. Antithrombotic therapy for venous thromboembolic disease.
    Hyers TM; Agnelli G; Hull RD; Weg JG; Morris TA; Samama M; Tapson V
    Chest; 1998 Nov; 114(5 Suppl):561S-578S. PubMed ID: 9822063
    [No Abstract]   [Full Text] [Related]  

  • 20. Tinzaparin sodium: a review of its pharmacology and clinical use in the prophylaxis and treatment of thromboembolic disease.
    Cheer SM; Dunn CJ; Foster R
    Drugs; 2004; 64(13):1479-502. PubMed ID: 15212562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.